Edges in Network
Network | GSE5851_top8000 - GSE5851 - SiGN-BN NNSR |
Network Description | Phase II exploratory pharmacogenomics study of cetuximab monotherapy in patients with advanced metastatic CRC |
Node | SLC2A3 |
Upstream (Parents) |
---|
(<<) SLC2A14///SLC2A3 → SLC2A3 |
(<<) TREM1 → SLC2A3 |
(<<) EGLN3 → SLC2A3 |
(<<) RORC → SLC2A3 |
(<<) EMP1 → SLC2A3 |
(<<) BCL2A1 → SLC2A3 |
Downstream (Children) |
---|
SLC2A3 → SLC2A14///SLC2A3 (>>) |
SLC2A3 → NAALADL1 (>>) |
SLC2A3 → APBA1 (>>) |
SLC2A3 → IGF2BP3 (>>) |
SLC2A3 → RFPL1 (>>) |
SLC2A3 → FUT9 (>>) |
SLC2A3 → NFE2 (>>) |
SLC2A3 → KRT35 (>>) |
SLC2A3 → SLC16A8 (>>) |